天和防務(300397.SZ)擬推2021年員工持股計劃
格隆匯11月14日丨天和防務(300397.SZ)發佈2021年員工持股計劃(草案),該計劃(草案)獲股東大會批准後,該員工持股計劃設立時的規模總額上限為1.2億元。
本期員工持股計劃的參與對象為公司董事(不含獨立董事及外部董事)、監事(不含外部監事)、高級管理人員和其他員工,總人數不超過508人,具體參加人數根據員工實際繳款情況確定。
該計劃擬通過資管/信託產品、金融機構融資等法律法規允許的方式實現融資金額與其餘資金的比例不超過 1:1,最終融資情況及融資金額以提供融資的主體審批結果為準。該員工持股計劃的融資金額不超過6000萬元,其餘資金金額不超過6000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.